David Bennett to Idiopathic Pulmonary Fibrosis
This is a "connection" page, showing publications David Bennett has written about Idiopathic Pulmonary Fibrosis.
Connection Strength
0.892
-
Galactin-1, 3 and 9: Potential biomarkers in idiopathic pulmonary fibrosis and other interstitial lung diseases. Respir Physiol Neurobiol. 2020 11; 282:103546.
Score: 0.729
-
Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib. Respir Investig. 2019 May; 57(3):290-291.
Score: 0.164